|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to cash used in operating activities: | ||
| Share-based compensation expense | ||
| Depreciation | ||
| Redeemable preferred shares fair value adjustment | ||
| Depreciation and amortization | ||
| Loss on US joint venture consolidation | ||
| Reduction in the carrying amount of lease assets | ||
| Warrant liability fair value adjustment | ||
| Convertible note fair value adjustment | ||
| Share of net loss of equity method investee | ||
| Foreign currency transaction net unrealized gain | ||
| Other | ||
| Changes in assets and liabilities: | ||
| Prepaid assets | ||
| Other current assets | ||
| Prepaid assets and other current assets | ||
| Other long-term assets | ||
| Accounts payable, accrued liabilities and other | ||
| Accounts payable and accrued liabilities - related party | ||
| Other current liabilities | ||
| Deferred income | ||
| Operating lease liability | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Proceeds from property related grants | ||
| Purchases of property and equipment | ||
| Investment in convertible note | ||
| Investments in equity method investee | ||
| Asset acquisition, cash acquired | ||
| Investments in convertible note | ||
| Purchases of other long-term assets | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from issuance of ordinary shares, net | ||
| Issuance cost | ||
| Repurchase of treasury shares | ||
| Proceeds from Business Combination | ||
| Proceeds from PIPE Investment, net | ||
| Proceeds from issuance of redeemable preferred shares | ||
| Payments for the Norway Demerger | ||
| Net cash provided by financing activities | ||
| Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | ||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | ||
| Cash, cash equivalents, and restricted cash at beginning of period | ||
| Cash, cash equivalents, and restricted cash at end of period | ||
| Supplementary disclosures of cash flow information | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| Supplementary disclosures for noncash activities | ||
| Warranty liability assumed from business combination | ||
| Settlement of redeemable preferred shares through issuance of ordinary shares | ||
| Accrued purchases of property and equipment | ||
| Reclassification of share-based compensation expense from equity to liability | ||
| Accrued purchases of property and equipment and intangible assets | ||
| Investment in equity method investment through assumption of liability | ||
| Settlement of accrued liabilities through issuance of non-employee warrants | ||
| Settlement of other long-term liabilities through issuance of employee options | ||
| Net liabilities assumed from Business Combination | ||
| Reconciliation to consolidated balance sheets: | ||
| Cash and cash equivalents | ||
| Restricted cash | ||
| Cash, cash equivalents, and restricted cash |
Loading...
